CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms

被引：0

作者：

Yuanpei Wang

Jing Wen

Xiangyi Sun

Yi Sun

Yuchen Liu

Xiaoran Cheng

Weijia Wu

Qianwen Liu

Fang Ren

机构：

[1] The First Affiliated Hospital of Zhengzhou University,Department of Gynecology

[2] The First Affiliated Hospital of Zhengzhou University,Department of Pharmacy

来源：

Cancer Chemotherapy and Pharmacology | 2024年 / 93卷

关键词：

Ovarian cancer; CUDC-907; PI3K; HDAC; c-Myc;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：295 / 306

页数：11

共 50 条

[1] CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms
Wang, Yuanpei
Wen, Jing
Sun, Xiangyi
Sun, Yi
Liu, Yuchen
Cheng, Xiaoran
Wu, Weijia
Liu, Qianwen
Ren, Fang
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (04) : 295 - 306
[2] Synergistic antitumor effect of MK-1775 and CUDC-907 against prostate cancer
Ma, Saisai
Xu, Yichen
Liu, Minmin
Wu, Shuaida
Zhang, Ye
Xia, Hongyan
Lu, Ji
Zhan, Yang
INVESTIGATIONAL NEW DRUGS, 2025, 43 (01) : 157 - 166
[3] CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
Fu, Xu-hong
Zhang, Xiong
Yang, Hong
Xu, Xiao-wei
Hu, Zong-long
Yan, Juan
Zheng, Xing-ling
Wei, Rong-rui
Zhang, Zhu-qing
Tang, Shi-rui
Geng, Mei-yu
Huang, Xun
ACTA PHARMACOLOGICA SINICA, 2019, 40 (05) : 677 - 688
[4] CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
Xu-hong Fu
Xiong Zhang
Hong Yang
Xiao-wei Xu
Zong-long Hu
Juan Yan
Xing-ling Zheng
Rong-rui Wei
Zhu-qing Zhang
Shi-rui Tang
Mei-yu Geng
Xun Huang
Acta Pharmacologica Sinica, 2019, 40 : 677 - 688
[5] The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML
Xinan Qiao
Jun Ma
Tristan Knight
Yongwei Su
Holly Edwards
Lisa Polin
Jing Li
Juiwanna Kushner
Sijana H. Dzinic
Kathryn White
Jian Wang
Hai Lin
Yue Wang
Liping Wang
Guan Wang
Jeffrey W. Taub
Yubin Ge
Blood Cancer Journal, 11
[6] The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML
Qiao, Xinan
Ma, Jun
Knight, Tristan
Su, Yongwei
Edwards, Holly
Polin, Lisa
Li, Jing
Kushner, Juiwanna
Dzinic, Sijana H.
White, Kathryn
Wang, Jian
Lin, Hai
Wang, Yue
Wang, Liping
Wang, Guan
Taub, Jeffrey W.
Ge, Yubin
BLOOD CANCER JOURNAL, 2021, 11 (06)
[7] SY-1365, a selective CDK7 inhibitor, exhibits potent antitumor activity against ovarian cancer models in vitro and in vivo
Konstantinopoulos, Panagiotis A.
Hodgson, Graeme
Rajagopal, Nisha
Johannessen, Liv
Liu, Joyce F.
Kirschmeier, Paul T.
Zhou, Shan
Cam Anh Tran
Orlando, David
Fritz, Christian
di Tomaso, Emmanuelle
Matulonis, Ursula A.
CANCER RESEARCH, 2018, 78 (13)
[8] Arginine methyltransferase inhibitor 1 exhibits antitumor effects against cervical cancer in vitro and in vivo
Dong, Shu-Hong
Wang, Xing
Tian, San-Chun
Ma, Neng-Qian
Zhang, Xin-Yang
Liu, Yapeng
Zhang, Bao-Lai
Wu, Yong-Jie
PHARMAZIE, 2018, 73 (05): : 269 - 273
[9] Glabridin exhibits potent inhibitory effects against Toxoplasma gondii in vitro and in vivo
Wang, Lu
Zhai, Bintao
Wang, Chen
Elsheikha, Hany M.
Guo, Haiting
Zheng, Xiao-Nan
Zhou, Chun-Xue
Zhu, Xing-Quan
PARASITES & VECTORS, 2024, 17 (01):
[10] Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo
Wei, Yan-lin
Xu, Lei
Liang, Yun
Xu, Xiao-hua
Zhao, Xiao-ying
ACTA PHARMACOLOGICA SINICA, 2009, 30 (04) : 451 - 457

← 1 2 3 4 5 →